Real-World Evidence Studies in Mexico

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Real-World Evidence Studies in Mexico

Real-World Evidence Studies in Mexico – Full Service CRO

Real-world evidence (RWE) studies have emerged as a powerful tool to assess the safety, effectiveness, and value of healthcare interventions in real-world settings. In Mexico, RWE studies are gaining momentum and playing a crucial role in informing healthcare decision-making.

This blog explores the significance of RWE studies in Mexico, their impact on healthcare policies and practices, and the potential benefits they offer to patients, healthcare providers, and the overall healthcare system.

What is Real-World Evidence?

Real-world evidence refers to data collected from routine clinical practice, including electronic health records, claims databases, patient registries, and other sources. Unlike traditional clinical trials, RWE studies analyze data from diverse patient populations in real-world settings to generate insights into the effectiveness, safety, and utilization of medical interventions.

The Importance of Real-World Evidence Studies in Mexico

  1. Enhancing Generalizability: RWE studies provide a broader representation of patients and healthcare practices in Mexico, allowing for more generalizable results compared to controlled clinical trials conducted in specific populations.
  2. Informing Decision-Making: RWE studies offer valuable insights to policymakers, healthcare providers, and payers when making informed decisions about treatment options, reimbursement policies, and resource allocation.
  3. Identifying Real-World Outcomes: These studies capture real-world outcomes that are often missed in controlled environments, enabling a better understanding of the long-term benefits and risks associated with medical interventions.

Impact on Healthcare Policies and Practices

  1. Evidence-Based Decision-Making: RWE studies contribute to evidence-based decision-making by providing real-world data that can support the development of clinical guidelines, protocols, and health policies tailored to the Mexican population.
  2. Comparative Effectiveness Research: RWE studies enable comparisons between different interventions, helping identify the most effective treatment strategies and improving patient outcomes.
  3. Health Technology Assessment: RWE studies assist in evaluating the value and cost-effectiveness of new healthcare technologies, guiding coverage decisions and optimizing resource allocation.

Real-World Evidence Studies in Mexico

Real-World Evidence Studies in Mexico

Real-World Evidence Studies in Mexico

Benefits to Patients

  1. Access to Innovative Therapies: RWE studies can expedite the availability of new treatments by providing evidence of their real-world effectiveness, accelerating the process of regulatory approval and reimbursement.
  2. Patient-Centered Care: RWE studies focus on patient outcomes and experiences, enabling healthcare providers to make informed decisions aligned with individual patient needs, preferences, and diverse demographic factors.
  3. Safety Monitoring: RWE studies play a crucial role in post-marketing surveillance, identifying potential safety concerns and facilitating timely interventions to protect patient well-being.

Benefits to Healthcare Providers

  1. Practice Improvement: RWE studies offer healthcare providers insights into treatment patterns, healthcare utilization, and outcomes, enabling them to improve clinical practice, reduce variations in care, and enhance patient outcomes.
  2. Shared Decision-Making: RWE studies empower healthcare providers to engage in shared decision-making with patients, ensuring informed discussions about treatment options, potential risks, and expected outcomes.
  3. Continuous Learning: RWE studies facilitate the generation of new knowledge, allowing healthcare providers to stay updated on emerging therapies, treatment effectiveness, and safety profiles.

Benefits to the Healthcare System

  1. Resource Allocation: RWE studies assist in optimizing the allocation of healthcare resources by providing evidence on the cost-effectiveness and long-term outcomes of different interventions.
  2. Health Equity: RWE studies can help identify and address disparities in healthcare access, outcomes, and treatment responses among different populations within Mexico, leading to more equitable healthcare practices.
  3. Sustainable Healthcare: RWE studies contribute to building a sustainable healthcare system by promoting the appropriate utilization of resources, reducing unnecessary interventions, and improving patient outcomes.


Real-world evidence studies are playing a vital role in shaping healthcare policies and practices in Mexico. By leveraging data from real-world settings, these studies provide valuable insights into the safety, effectiveness, and value of healthcare interventions. The impact of RWE studies extends to patients, healthcare providers, and the healthcare system as a whole.

Real-World Evidence Studies in Mexico

Source: Roche

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Real-World Evidence Studies in Mexico

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Real-World Evidence Studies in Mexico

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Real-World Evidence Studies in Mexico

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Real-World Evidence Studies in Mexico

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Real-World Evidence Studies in Mexico

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Real-World Evidence Studies in Mexico

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Real-World Evidence Studies in Mexico

The Cohortias Team

Real-World Evidence Studies in Mexico

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Real-World Evidence Studies in Mexico

Network & Partnerships